日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The prognostic predictive SER model for NK/T-cell lymphoma in the era of modern immunotherapy

现代免疫疗法时代NK/T细胞淋巴瘤的预后预测SER模型

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-025-04108-y
Han, Runkun; Zhang, Denghan; Bai, Shenrui; Ma, Yifei; Xu, Bushu; Chen, Hao; Zhang, Ao
T细胞
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

The efficacy and safety of gemcitabine and docetaxel in pseudomyogenic hemangioendothelioma: a multi-center experience

吉西他滨联合多西他赛治疗假性肌源性血管内皮瘤的疗效和安全性：一项多中心研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14376-6
Cai, Qiyan; Xu, Bushu; Zhang, Peng; Ma, Jie; Liang, Jiahui; Le, Liyuan; Li, Shining; Yang, Jing; Pan, Qiuzhong; Peng, Ruiqing; Zhang, Xing
心血管
发表日期：2025
文献求助 收藏

Novel Location-Grading-Node-Metastasis Staging System in Patients With Head and Neck Soft Tissue Sarcoma

头颈部软组织肉瘤患者的新型位置-分级-淋巴结-转移分期系统

期刊:Journal of Otolaryngology-Head & Neck Surgery
影响因子:2.2
doi:10.1177/19160216251333359
Du, Dingfu; Wu, Shaojun; Wang, Zilu; Guan, Yuanxiang; Jiang, Ke; Xu, Bushu; Liang, Yao
发表日期：2025
文献求助 收藏

Anlotinib as a maintenance treatment for advanced soft tissue sarcoma after first-line chemotherapy (ALTER-S006): a multicentre, open-label, single-arm, phase 2 trial

安罗替尼作为一线化疗后晚期软组织肉瘤的维持治疗（ALTER-S006）：一项多中心、开放标签、单臂 II 期试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.102240
Xu, Bushu; Pan, Qiuzhong; Pan, Hua; Li, Haomiao; Li, Xianan; Chen, Jing; Pang, Danmei; Zhang, Baoqing; Weng, Desheng; Peng, Ruiqing; Fang, Meiyu; Zhang, Xing
发表日期：2023
文献求助 收藏

LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival

软组织肉瘤中肿瘤浸润T细胞上LAG-3的表达与不良生存率相关

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2018.0306
Que, Yi; Fang, Zhixin; Guan, Yuanxiang; Xiao, Wei; Xu, Bushu; Zhao, Jingjing; Chen, Huoying; Zhang, Xinke; Zeng, Musheng; Liang, Yao; Zhang, Xing
肿瘤
T细胞
肿瘤免疫
T细胞
细胞生物学
免疫/内分泌
发表日期：2019
文献求助 收藏

Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patients.

比较 MAID (AI) 和 CAV/IE 方案与环磷酸腺苷反应元件结合蛋白 3 样蛋白 1 (CREB3L1) 在晚期软组织肉瘤患者姑息化疗中的预测价值

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.28734
Xiao Wei, Liang Yao, Que Yi, Li Jingjing, Peng Ruiqing, Xu Bushu, Wen Xizhi, Zhao Jingjing, Guan Yuanxiang, Zhang Xing
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏